Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00311779 · ClinicalTrials.gov registry record · Phase 2
A Dose Ranging Study of Different Strengths of Spinosad Topical Creme in Subjects With Pediculosis Capitis
A Phase 2 study, sponsored by ParaPRO.
- Completed
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
NCT00311779 is a Phase 2 study that has completed, run by ParaPRO. The registered enrollment target is 120 participants.
The verdict
NCT00311779, a Phase 2 study, has completed, sponsored by ParaPRO.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
Study Summary
The primary objective of the study is to determine the safety and efficacy of different strengths of Spinosad topical creme, as compared to a vehicle control, in subjects who have been infested with at least a mild case of Pediculosis capitis (head lice).
Interventions
- DRUG Spinosad Creme Rinse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2006-03 |
| Est. Completion | 2006-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00311779
The ClinicalTrials.gov registry entry for NCT00311779 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ParaPRO, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Spinosad Creme Rinse is the first listed.
NCT00311779 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00311779 about?
NCT00311779 is a clinical study titled "A Dose Ranging Study of Different Strengths of Spinosad Topical Creme in Subjects With Pediculosis Capitis". The primary objective of the study is to determine the safety and efficacy of different strengths of Spinosad topical creme, as compared to a vehicle control, in subjects who have been infested with at least a mild case of Pediculosis capitis (head lice).
What is the current status of trial NCT00311779?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2006-03. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00311779?
The interventions under investigation include: Spinosad Creme Rinse (DRUG).
Who is sponsoring clinical trial NCT00311779?
This trial is sponsored by ParaPRO, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.